Abstract
Abstract only
- Title
- A phase 2, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma
- Creators
- Amir A. Jazaeri - University of VirginiaRobert P. Edwards - Magee-Womens HospitalRobert Michael Wenham - Moffitt Cancer CenterKOJI Matsuo - University of Southern CaliforniaGini F. Fleming - University of ChicagoDavid M. O'Malley - The Ohio State UniversityBrian M. Slomovitz - University of MiamiBradley J. Monk - University of ArizonaRobert James Brown - Iovance Biotherapeutics, Inc, San Carlos, CASamuel Suzuki - Theravance BiopharmaIgor Gorbatchevsky - Theravance BiopharmaMaria Fardis - Theravance BiopharmaEmese Zsiros - Roswell Park Cancer Institute
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.TPS5604-TPS5604
- Identifiers
- 991005968792002656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article